HK1037910A1 - Use of creatine compounds for treatment of bone or cartilage cells and tissues - Google Patents
Use of creatine compounds for treatment of bone or cartilage cells and tissuesInfo
- Publication number
- HK1037910A1 HK1037910A1 HK01107749A HK01107749A HK1037910A1 HK 1037910 A1 HK1037910 A1 HK 1037910A1 HK 01107749 A HK01107749 A HK 01107749A HK 01107749 A HK01107749 A HK 01107749A HK 1037910 A1 HK1037910 A1 HK 1037910A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bone
- treatment
- creatine compounds
- tissues
- cartilage cells
- Prior art date
Links
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical class NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title abstract 3
- 210000002449 bone cell Anatomy 0.000 title 1
- 210000003321 cartilage cell Anatomy 0.000 title 1
- 210000001519 tissue Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 210000000845 cartilage Anatomy 0.000 abstract 2
- 230000007547 defect Effects 0.000 abstract 2
- 230000035876 healing Effects 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 230000008733 trauma Effects 0.000 abstract 2
- 239000007943 implant Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3847—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1998/004713 WO2000006150A1 (en) | 1998-07-28 | 1998-07-28 | Use of creatine compounds for treatment of bone or cartilage cells and tissues |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1037910A1 true HK1037910A1 (en) | 2002-02-22 |
Family
ID=8167021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01107749A HK1037910A1 (en) | 1998-07-28 | 2001-11-06 | Use of creatine compounds for treatment of bone or cartilage cells and tissues |
Country Status (11)
Country | Link |
---|---|
US (2) | US20020039567A1 (ja) |
EP (1) | EP1100488B1 (ja) |
JP (1) | JP4778143B2 (ja) |
AT (1) | ATE238049T1 (ja) |
CA (1) | CA2338712C (ja) |
DE (1) | DE69813908T2 (ja) |
DK (1) | DK1100488T3 (ja) |
ES (1) | ES2198067T3 (ja) |
HK (1) | HK1037910A1 (ja) |
PT (1) | PT1100488E (ja) |
WO (1) | WO2000006150A1 (ja) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242491B1 (en) * | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
US7005274B1 (en) * | 1999-09-15 | 2006-02-28 | Migenix Corp. | Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
US6811776B2 (en) | 2000-12-27 | 2004-11-02 | The Regents Of The University Of Michigan | Process for ex vivo formation of mammalian bone and uses thereof |
CA2395957A1 (en) * | 1999-12-28 | 2001-07-05 | The Regents Of The University Of Michigan | Process for ex vivo formation of mammalian bone and uses thereof |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
EP2206772A3 (en) * | 2000-12-06 | 2010-08-04 | Robert J. Hariri | Method of collecting placental stem cells |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
CN1498266A (zh) * | 2001-01-30 | 2004-05-19 | 使用滑膜衍生的组织或细胞治疗及修复关节软骨缺损或损伤的组合物及方法 | |
MX348185B (es) * | 2001-02-14 | 2017-06-02 | Anthrogenesis Corp | Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella. |
EP2316918B1 (en) * | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US7700090B2 (en) | 2002-02-13 | 2010-04-20 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
KR20050075507A (ko) * | 2004-01-15 | 2005-07-21 | 재단법인서울대학교산학협력재단 | 시클로크레아틴을 포함하는 골대사성 질환의 예방 및치료를 위한 조성물 |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
US7736669B2 (en) * | 2004-11-30 | 2010-06-15 | University Of Washington | Porous structures, and methods of use |
JP4914594B2 (ja) * | 2005-09-29 | 2012-04-11 | ユニテックフーズ株式会社 | 関節痛改善用食品組成物 |
RS53210B (en) | 2005-10-13 | 2014-08-29 | Anthrogenesis Corporation | IMMUNOMODULATION USING PLACENTA CELL CELLS |
CA2630077C (en) | 2005-11-17 | 2014-07-15 | Biomimetic Therapeutics, Inc. | Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix |
WO2007079183A2 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Placental stem cell populations |
US8189737B2 (en) * | 2006-01-26 | 2012-05-29 | The Board Of Regents, The University Of Texas System, A Texas Institution Of Higher Learning | Process and apparatus for microCT imaging of ex vivo specimens |
EP1991282B1 (en) | 2006-02-09 | 2013-06-19 | BioMimetic Therapeutics, LLC | Compositions and methods for treating bone |
WO2007126924A1 (en) * | 2006-03-28 | 2007-11-08 | University Of South Carolina | Method for stimulating proteoglycan synthesis in cells |
KR20090031895A (ko) * | 2006-06-09 | 2009-03-30 | 안트로제네시스 코포레이션 | 태반 니치 및 줄기 세포 배양을 위한 이의 용도 |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
CA2656278C (en) | 2006-06-30 | 2016-02-09 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating rotator cuff injuries |
EP2086598B1 (en) | 2006-11-03 | 2015-05-27 | BioMimetic Therapeutics, LLC | Compositions and methods for arthrodetic procedures |
DE102007004781A1 (de) | 2007-01-31 | 2008-08-07 | Alzchem Trostberg Gmbh | Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels |
RS52921B (en) | 2007-02-12 | 2014-02-28 | Anthrogenesis Corporation | TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS |
JP4818177B2 (ja) * | 2007-03-27 | 2011-11-16 | ユニテックフーズ株式会社 | 高齢者向け骨・筋肉増強促進組成物 |
JP5157007B2 (ja) * | 2007-05-11 | 2013-03-06 | ビーエイチエヌ株式会社 | 骨強化剤 |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
US20090105196A1 (en) * | 2007-06-22 | 2009-04-23 | Belinda Tsao Nivaggioli | Use of creatine compounds to treat dermatitis |
DE102007030495A1 (de) | 2007-06-30 | 2009-01-15 | Alzchem Trostberg Gmbh | Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände |
PL2203176T3 (pl) | 2007-09-28 | 2015-05-29 | Anthrogenesis Corp | Hamowanie nowotworu za pomocą perfuzatu łożyska ludzkiego i ludzkich łożyskowych pośrednich komórek NK |
DE102007053369A1 (de) | 2007-11-09 | 2009-07-02 | Alzchem Trostberg Gmbh | Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit |
DE102007062288A1 (de) | 2007-12-21 | 2009-06-25 | Alzchem Trostberg Gmbh | Kreatin-Zubereitung und Verfahren zu deren Herstellung |
CN102014977B (zh) | 2008-02-07 | 2015-09-02 | 生物模拟治疗有限责任公司 | 用于牵引成骨术的组合物和方法 |
US10104880B2 (en) | 2008-08-20 | 2018-10-23 | Celularity, Inc. | Cell composition and methods of making the same |
KR20200143506A (ko) * | 2008-08-20 | 2020-12-23 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
CA2965883C (en) | 2008-08-22 | 2020-05-12 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
KR20110067035A (ko) | 2008-09-09 | 2011-06-20 | 바이오미메틱 세라퓨틱스, 인크. | 건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법 |
US7874536B2 (en) * | 2008-09-26 | 2011-01-25 | Groover David O | Angle ceiling hanger or bracket |
US8367409B2 (en) | 2008-11-19 | 2013-02-05 | Anthrogenesis Corporation | Amnion derived adherent cells |
EP2375907B1 (en) * | 2008-11-21 | 2019-02-27 | Celularity, Inc. | Treatment of diseases, disorders or conditions of the lung using placental cells |
ES2646750T3 (es) * | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias |
WO2011103598A1 (en) | 2010-02-22 | 2011-08-25 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
EP3088512B1 (en) | 2010-04-07 | 2019-12-11 | Celularity, Inc. | Use of placental stem cells for treating heart and circulatory diseases by promoting angiogenesis |
MX2012011543A (es) | 2010-04-08 | 2013-05-06 | Anthrogenesis Corp | Tratamiento de sarcoidosis empleando celulas madre placentarias. |
EP2577290A1 (en) * | 2010-06-07 | 2013-04-10 | Fritz-Lipmann-Institut e.V. Leibniz-Institut für Altersforschung | Agent against glucocorticoid-induced osteoporosis |
EP2593542B1 (en) | 2010-07-13 | 2018-01-03 | Anthrogenesis Corporation | Methods of generating natural killer cells |
JP5756614B2 (ja) * | 2010-11-02 | 2015-07-29 | 花王株式会社 | オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤 |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
US9157908B2 (en) | 2011-04-22 | 2015-10-13 | University Of Washington Through Its Center For Commercialization | Chitosan-alginate scaffold cell culture system and related methods |
CN113559126A (zh) | 2011-06-01 | 2021-10-29 | 人类起源公司 | 利用胎盘干细胞治疗疼痛 |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
CN102897735B (zh) * | 2012-11-12 | 2014-07-16 | 中国科学院上海硅酸盐研究所 | 微波辅助制备羟基磷灰石空心球 |
WO2014123879A1 (en) | 2013-02-05 | 2014-08-14 | Anthrogenesis Corporation | Natural killer cells from placenta |
US11318166B2 (en) | 2014-06-04 | 2022-05-03 | Cedars-Sinai Medical Center | Method for non surgical repair of vertebral compression fractures |
EP3415527A1 (de) | 2017-06-14 | 2018-12-19 | Technische Universität Dresden | Verwendung der extrazellulären domäne des transferrinrezeptor 2 zur diagnostik und behandlung von primär und sekundär sklerosierenden erkrankungen |
CN112236166A (zh) * | 2018-06-13 | 2021-01-15 | 科马布有限公司 | 用于治疗骨疾病的转铁蛋白受体-2的拮抗剂和激动剂 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692433A (en) * | 1983-10-12 | 1987-09-08 | The Regents Of The University Of California | Method and composition for regulating serum calcium levels of mammals |
US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
US4772591A (en) * | 1985-09-25 | 1988-09-20 | Peritain, Ltd. | Method for accelerated wound healing |
US5693615A (en) * | 1991-06-05 | 1997-12-02 | The Procter & Gamble Company | Therapeutic compositions for osteoinduction |
JPH05238929A (ja) * | 1992-02-27 | 1993-09-17 | Sumitomo Pharmaceut Co Ltd | 代謝性骨疾患治療用長期持続性製剤 |
JPH07157439A (ja) * | 1993-12-07 | 1995-06-20 | Eisai Co Ltd | 骨内部埋め込み用製剤 |
DE69535104T2 (de) * | 1994-11-08 | 2007-02-08 | Avicena Group, Inc., Cambridge | Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose |
DK0811383T3 (da) * | 1995-02-20 | 2007-06-25 | Yukio Kato | Lægemidler til arthrosis deformans og inflammatoriske ledsygdomme |
BR9608344A (pt) * | 1995-06-06 | 1999-01-05 | Osteogenics Inc | Formulações de hidroxiapatita biocompatível e usos das mesmas |
DE19529223A1 (de) * | 1995-08-09 | 1997-02-13 | Boehringer Mannheim Gmbh | Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau |
EP0854712B1 (en) * | 1995-10-11 | 2003-05-07 | Avicena Group, Inc. | Use of creatine analogues for the treatment of disorders of glucose metabolism |
US5998457A (en) * | 1995-10-26 | 1999-12-07 | Avicena Group, Inc. | Creatine analogues for treatment of obesity |
AU3214797A (en) * | 1996-05-28 | 1998-01-05 | Regents Of The University Of Michigan, The | Engineering oral tissues |
US5716926A (en) * | 1996-07-26 | 1998-02-10 | Paxton K. Beale | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
US5756469A (en) * | 1996-07-26 | 1998-05-26 | Beale; Paxton K. | Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
US5942534A (en) * | 1996-10-10 | 1999-08-24 | The General Hospital Corporation | Photodynamic therapy for the treatment of osteoarthritis |
US5888553A (en) * | 1997-04-08 | 1999-03-30 | Infinity, Inc. | Non-steroidal anabolic composition |
US5886040A (en) * | 1997-06-17 | 1999-03-23 | Amt Labs, Inc. | Creatine pyruvate salt with enhanced palatability |
EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
-
1998
- 1998-07-28 EP EP98942645A patent/EP1100488B1/en not_active Expired - Lifetime
- 1998-07-28 ES ES98942645T patent/ES2198067T3/es not_active Expired - Lifetime
- 1998-07-28 AT AT98942645T patent/ATE238049T1/de not_active IP Right Cessation
- 1998-07-28 DK DK98942645T patent/DK1100488T3/da active
- 1998-07-28 DE DE69813908T patent/DE69813908T2/de not_active Expired - Lifetime
- 1998-07-28 PT PT98942645T patent/PT1100488E/pt unknown
- 1998-07-28 CA CA2338712A patent/CA2338712C/en not_active Expired - Fee Related
- 1998-07-28 JP JP2000562005A patent/JP4778143B2/ja not_active Expired - Fee Related
- 1998-07-28 WO PCT/EP1998/004713 patent/WO2000006150A1/en active IP Right Grant
-
2001
- 2001-01-26 US US09/769,404 patent/US20020039567A1/en not_active Abandoned
- 2001-11-06 HK HK01107749A patent/HK1037910A1/xx not_active IP Right Cessation
-
2004
- 2004-12-07 US US11/005,942 patent/US20050085543A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK1100488T3 (da) | 2003-08-11 |
WO2000006150A1 (en) | 2000-02-10 |
JP4778143B2 (ja) | 2011-09-21 |
US20020039567A1 (en) | 2002-04-04 |
EP1100488A1 (en) | 2001-05-23 |
DE69813908D1 (de) | 2003-05-28 |
DE69813908T2 (de) | 2004-02-05 |
CA2338712A1 (en) | 2000-02-10 |
ES2198067T3 (es) | 2004-01-16 |
EP1100488B1 (en) | 2003-04-23 |
JP2002521440A (ja) | 2002-07-16 |
US20050085543A1 (en) | 2005-04-21 |
ATE238049T1 (de) | 2003-05-15 |
PT1100488E (pt) | 2003-09-30 |
CA2338712C (en) | 2012-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1037910A1 (en) | Use of creatine compounds for treatment of bone or cartilage cells and tissues | |
Granströ et al. | Bone-anchored reconstruction of the irradiated head and neck cancer patient | |
Nishimura et al. | Auricular prostheses and osseointegrated implants: UCLA experience | |
Spiessl | New concepts in maxillofacial bone surgery | |
Brånemark et al. | Reconstruction of the defective mandible | |
SNYDER et al. | Mandibulo-facial restoration with live osteocutaneous flaps | |
Weischer et al. | Ten-year experience in oral implant rehabilitation of cancer patients: treatment concept and proposed criteria for success. | |
Boyd et al. | The iliac crest and the radial forearm flap in vascularized oromandibular reconstruction | |
Reinert et al. | Stability of bone grafting and placement of implants in the severely atrophic maxilla | |
Tolman et al. | Extraoral application of osseointegrated implants | |
AU6788694A (en) | Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases | |
Ueda et al. | Effect of hyperbaric oxygen therapy on osseointegration of titanium implants in irradiated bone: a preliminary report. | |
Jacobsson et al. | Tissue-integrated implants in children | |
Johnsson et al. | The effects of hyperbaric oxygenation on bone-titanium implant interface strength with and without preceding irradiation. | |
Schwartz et al. | Mandibular reconstruction using the dacron-urethane prosthesis and autogenic cancellous bone: review of 32 cases | |
Peckitt | Stereoscopic lithography: customized titanium implants in orofacial reconstruction | |
Kerr et al. | The effect of ultrasound on bone dimensional changes following extraction: a pilot study | |
Marker et al. | Osseointegrated implants for prosthetic rehabilitation after treatment of cancer of the oral cavity | |
Cohen et al. | Mandibular reconstruction | |
Zhang et al. | Reconstruction of mandible with fibular flap and dental implant distractor: a new approach | |
Cummings | Experimental observations of canine mandibular regeneration following segmental removal, freezing, and reimplantation | |
RU2359621C1 (ru) | Способ хирургического лечения рака гортани | |
El-Sheikh et al. | The split rib bundle graft in mandibular reconstruction | |
Punjabi et al. | Late complications of mandibular fractures | |
Schlegel et al. | Clinical Trial of Modified Ankylos Implants for Extraoral Use in Cranio-and Maxillofacial Surgery. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150728 |